Literature DB >> 22901217

Metabolic changes enhance the cardiovascular risk with differentiated thyroid carcinoma--a case control study from Manipal Teaching Hospital of Nepal.

Ankush Mittal1, Bibek Poudel, Dipendra Raj Pandeya, Satrudhan Pd Gupta, Brijesh Sathian, Shambhu Kumar Yadav.   

Abstract

OBJECTIVE: To evaluate several metabolic changes in patients with differentiated thyroid carcinoma (DTC ) which enhance cardiovascular risk in the western region of Nepal.
MATERIALS AND METHODS: This hospital based case control study was carried out using data retrieved from the register maintained in the Department of Biochemistry of the Manipal Teaching Hospital, Pokhara, Nepal between 1st January, 2009 and 31st December, 2011. The variables collected were age, gender, BMI, glucose, insulin, HbA1C, CRP, fibrinogen, total cholesterol, triglycerides, HDL, LDL, VLDL, f-T3, f-T4, TSH. One way ANOVA was used to examine statistical significance of differences between groups, along with the Post Hoc test LSD for comparison of means.
RESULTS: fT3 values were markedly raised in DTC cases (5.7±SD1.4) when compared to controls (2.2±SD0.9). Similarly, fT4 values were also moderately raised in cases of DTC (4.9±SD1.3 and 1.7 ±SD0.9). In contrast, TSH values were lowered in DTC cases (0.39±SD0.4) when compared to controls (4.2 ±SD 1.4). Mean blood glucose levels were decreased while insulin was increased and HDL reduced (39.5±SD4.7 as compared to the control 43.1±SD2.2).
CONCLUSION: Cardiovascular risk may be aggravated by insulin resistance, a hypercoagulable state, and an atherogenic lipid profile in patients with differentiated thyroid cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22901217     DOI: 10.7314/apjcp.2012.13.5.2335

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  4 in total

Review 1.  Long-term treatment-related morbidity in differentiated thyroid cancer: a systematic review of the literature.

Authors:  William Ae Parker; Ovie Edafe; Sabapathy P Balasubramanian
Journal:  Pragmat Obs Res       Date:  2017-05-16

Review 2.  Oncometabolites as biomarkers in thyroid cancer: a systematic review.

Authors:  Fatemeh Khatami; Moloud Payab; Masoumeh Sarvari; Kambiz Gilany; Bagher Larijani; Babak Arjmand; Seyed Mohammad Tavangar
Journal:  Cancer Manag Res       Date:  2019-02-25       Impact factor: 3.989

3.  High prevalence of thyroid carcinoma in patients with insulin resistance: a meta-analysis of case-control studies.

Authors:  Junyu Zhao; Qianping Zhang; Yupeng Yang; Jinming Yao; Lin Liao; Jianjun Dong
Journal:  Aging (Albany NY)       Date:  2021-09-22       Impact factor: 5.682

4.  Abnormal Glucose Metabolism Parameters and the Aggressiveness of Differentiated Thyroid Carcinoma: A Hospital-Based Cross-Section Study in China.

Authors:  Junyu Zhao; Yutian Tian; Zhen Jia; Jinming Yao; Lin Liao; Jianjun Dong
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-01       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.